Literature DB >> 17681492

Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance.

Hui-Wen Lo1, Francis Ali-Osman.   

Abstract

The human glutathione S-transferase, GSTs, possess both enzymatic and non-enzymatic functions and are involved in many important cellular processes, such as, phase II metabolism, stress response, cell proliferation, apoptosis, oncogenesis, tumor progression and drug resistance. The non-enzymatic functions of GSTs involve their interactions with cellular proteins, such as, JNK, TRAF, ASK, PKC, and TGM2, during which, either the interacting protein partner undergoes functional alteration or the GST protein itself is post-translationally modified and/or functionally altered. The majority of GST genes harbor polymorphisms that influence their transcription and/or function of their encoded proteins. This overview focuses on recent insights into the biology and pharmacogenetics of GSTs as a determinant of cancer drug resistance and response of cancer patients to therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681492     DOI: 10.1016/j.coph.2007.06.009

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  59 in total

1.  Mitogen-activated protein kinase (MAPK) hyperactivation and enhanced NRAS expression drive acquired vemurafenib resistance in V600E BRAF melanoma cells.

Authors:  Michael Lidsky; Gamil Antoun; Paul Speicher; Bartley Adams; Ryan Turley; Christi Augustine; Douglas Tyler; Francis Ali-Osman
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

2.  Ethnic differences in the association of the glutathione S-transferase T1 (GSTT1) null genotype and risk of gastric carcinoma: a systematic review and meta-analysis.

Authors:  Jeongmin Yoon; Myung-Han Hyun; Jong-Pill Yang; Min-Jeong Park; Sungsoo Park
Journal:  Mol Biol Rep       Date:  2014-02-22       Impact factor: 2.316

3.  Time to get Personal: A Framework for Personalized Targeting of Oxidative Stress in Neurotoxicity and Neurodegenerative Disease.

Authors:  Matthew Neal; Jason R Richardson
Journal:  Curr Opin Toxicol       Date:  2018-02-15

4.  Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity.

Authors:  Danyelle M Townsend; Kenneth D Tew; Lin He; Jarrod B King; Marie H Hanigan
Journal:  Biomed Pharmacother       Date:  2008-09-07       Impact factor: 6.529

5.  Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.

Authors:  Elizabeth W LaPensee; Sandy J Schwemberger; Christopher R LaPensee; El Mustapha Bahassi; Scott E Afton; Nira Ben-Jonathan
Journal:  Carcinogenesis       Date:  2009-05-14       Impact factor: 4.944

Review 6.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

7.  Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma.

Authors:  Surya Rednam; Michael E Scheurer; Adekunle Adesina; Ching C Lau; Mehmet Fatih Okcu
Journal:  Pediatr Blood Cancer       Date:  2012-10-12       Impact factor: 3.167

8.  Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.

Authors:  P David Josephy
Journal:  Hum Genomics Proteomics       Date:  2010-06-13

9.  Molecular evolution and the role of oxidative stress in the expansion and functional diversification of cytosolic glutathione transferases.

Authors:  Rute R da Fonseca; Warren E Johnson; Stephen J O'Brien; Vítor Vasconcelos; Agostinho Antunes
Journal:  BMC Evol Biol       Date:  2010-09-15       Impact factor: 3.260

10.  Using expression and genotype to predict drug response in yeast.

Authors:  Douglas M Ruderfer; David C Roberts; Stuart L Schreiber; Ethan O Perlstein; Leonid Kruglyak
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.